|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4,665.00 JPY | +0.11% |
|
+1.19% | +1.86% |
Business description: Noevir Holdings Co., Ltd.
Number of employees: 1,354
Sales by Activity: Noevir Holdings Co., Ltd.
| Fiscal Period: September | 2021 (JPY) | 2022 (JPY) | 2023 (JPY) | 2024 (JPY) | 2025 (JPY) |
|---|---|---|---|---|---|
Cosmetics | 38.32B | 47.03B | 48.18B | 49.76B | 50.52B |
Pharmaceuticals & Health Food | 11.12B | 11.41B | 11.98B | 11.44B | 11.54B |
Other | 2.09B | 2.97B | 2.67B | 2.89B | 2.93B |
Unallocated Adjustment | -260M | -265M | -276M | -275M | -266M |
Geographical breakdown of sales: Noevir Holdings Co., Ltd.
| Fiscal Period: September | 2021 (JPY) | 2022 (JPY) | 2023 (JPY) | 2024 (JPY) | 2025 (JPY) |
|---|---|---|---|---|---|
Japan | 51.27B | 61.14B | 62.55B | 63.82B | 64.72B |
Executive Committee: Noevir Holdings Co., Ltd.
| Manager | Title | Age | Since |
|---|---|---|---|
Takashi Okura
CEO | Chief Executive Officer | 62 | - |
Mitsuyoshi Hanyu
CTO | Chief Tech/Sci/R&D Officer | - | 2019-12-04 |
Masanao Nakao
AUD | Comptroller/Controller/Auditor | - | - |
Ikkou Yoshida
IRC | Investor Relations Contact | 68 | 2013-11-30 |
Makoto Hashimoto
HRO | Human Resources Officer | - | - |
Composition of the Board of Directors: Noevir Holdings Co., Ltd.
| Director | Title | Age | Since |
|---|---|---|---|
Hiroshi Okura
CHM | Chairman | 89 | 2011-03-21 |
Takashi Okura
BRD | Director/Board Member | 62 | - |
Ikkou Yoshida
BRD | Director/Board Member | 68 | 2011-03-21 |
Kozo Matsushita
BRD | Director/Board Member | - | - |
Maho Kinami
BRD | Director/Board Member | 49 | 2017-12-06 |
Emima Abe
BRD | Director/Board Member | 46 | 2018-11-30 |
Ryo Tsuchida
BRD | Director/Board Member | 57 | 2021-11-30 |
Masanao Nakao
BRD | Director/Board Member | - | 2023-11-27 |
Mari Ishimitsu
BRD | Director/Board Member | 52 | 2021-11-30 |
Haruhi Kuroda
BRD | Director/Board Member | 38 | 2021-11-30 |
Holdings: Noevir Holdings Co., Ltd.
| Name | Equities | % | Valuation |
|---|---|---|---|
KEYENCE CORPORATION 0.01% | 35,788 | 0.01% | 13 M $ |
| 113,709 | 0% | 4 M $ | |
| 400 | 0% | 11 718 $ |
Company details: Noevir Holdings Co., Ltd.
Cosmetics & Perfumes
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.11% | +1.19% | -0.32% | -13.45% | 994M | |
| +0.01% | +6.17% | +19.20% | +4.69% | 243B | |
| +1.70% | -2.42% | +51.06% | - | 47.08B | |
| +0.35% | +0.24% | +6.15% | +22.29% | 17.77B | |
| +4.09% | +14.45% | +8.16% | -56.06% | 6.19B | |
| -1.48% | +9.02% | -34.71% | +63.53% | 5.22B | |
| +1.10% | -1.64% | +1.96% | -14.05% | 5B | |
| +0.44% | +1.51% | -16.26% | -41.46% | 3.97B | |
| -0.66% | +2.33% | +96.58% | +163.03% | 3.81B | |
| +3.42% | +3.30% | -29.54% | -18.63% | 2.81B | |
| Average | +0.92% | +3.52% | +10.23% | +12.21% | 33.6B | |
| Weighted average by Cap. | +0.36% | +7.27% | +21.67% | +6.38% |
Sector
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 4928 Stock
- Company Noevir Holdings Co., Ltd.
Select your edition
All financial news and data tailored to specific country editions
